Skip to Main Content

Paper Details

Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit.
Commun Med (Lond)
7
2023
ADAM12, CD274, IRS, PD-(L)1, PD-1, PD-L1, PD-[L]1, PDCD1, TOP2A, advanced cancer, advanced solid tumors, lung cancer, microsatellite, patient, patients, pembrolizumab, solid tumor, tumor, tumor types
Author NameAffiliation
Scott A Tomlins
Daniel H Hovelson
Eddy S YangO'Neal Comprehensive Cancer Center, University of Alabama at Birmingham School of Medicine
Eddy S YangO'Neal Comprehensive Cancer Center, University of Alabama at Birmingham School of Medicine
Suresh NairLehigh Valley Topper Cancer Institute
  • 1 - 5

Datasets

Release 1.2